Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial.
(2012) The Lancet — Vol. 380, n° 9851, p. 1396-1405 (2012)
Files
CamenzindE-Lancet2012.pdf
Restricted Access - Adobe PDF
- 519.31 KB
Details
- Authors
- Abstract
- Medtronic, Inc.
- Affiliations
Citations
Camenzind, E., Wijns, W., Mauri, L., Kurowski, V., Parikh, K., Gao, R., Bode, C., Greenwood, J. P., Boersma, E., Vranckx, P., McFadden, E., Serruys, P. W., O’Neil, W. W., Jorissen, B., Van Leeuwen, F., Steg, P. G., & PROTECT Steering Committee and Investigators. (2012). Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial. The Lancet, 380(9851), 1396-1405. https://doi.org/10.1016/S0140-6736(12)61336-1 (Original work published 2012)